Novavax (NVAX) Revenue (2010 - 2026)
Novavax (NVAX) posted quarterly Revenue of $139.5 million for Q1 2026, down 79.07% year-over-year from $666.7 million in Q1 2025, and down 5.18% quarter-over-quarter from $147.1 million in Q4 2025.
Novavax (NVAX) Revenue (2010 - 2026) Analysis & Trends
Novavax's Revenue history runs 17 years deep, the most recent figure standing at $139.5 million for Q1 2026.
- In Q1 2026, Revenue fell 79.07% year-over-year to $139.5 million; the TTM figure through Mar 2026 stood at $532.1 million (down 57.6% YoY), while the FY2025 annual figure was $1.1 billion, up 64.69% from the prior year.
- Revenue for Q1 2026 stood at $139.5 million, down from $147.1 million in the prior quarter.
- The five-year high for Revenue was $734.6 million in Q3 2022, with the low at $70.4 million in Q3 2025.
- The 5-year median for Revenue is $185.9 million (2022), against an average of $285.1 million.
- The sharpest annual moves came in 2023 and 2025: Revenue slumped 88.5% in 2023, then surged 610.3% in 2025.
- Novavax's Revenue stood at $357.4 million in 2022, then declined by 18.48% to $291.3 million in 2023, then sank by 69.69% to $88.3 million in 2024, then jumped by 66.61% to $147.1 million in 2025, then dropped by 5.18% to $139.5 million in 2026.
- Business Quant data shows NVAX's Revenue at $139.5 million in Q1 2026, $147.1 million in Q4 2025, and $70.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Novavax | 1.33 Bn | 607.37 Mn | 42.45 Mn | 56.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.70 Mn |
| Mar 31, 2026 | 139.51 Mn |
| Dec 31, 2025 | 147.14 Mn |
| Sep 30, 2025 | 70.45 Mn |
| Jun 30, 2025 | 175.00 Mn |
| Mar 31, 2025 | 666.66 Mn |
| Dec 31, 2024 | 88.31 Mn |
| Sep 30, 2024 | 84.51 Mn |
| Jun 30, 2024 | 415.48 Mn |
| Mar 31, 2024 | 93.86 Mn |
| Dec 31, 2023 | 291.34 Mn |
| Sep 30, 2023 | 186.99 Mn |
| Jun 30, 2023 | 424.43 Mn |
| Mar 31, 2023 | 80.95 Mn |
| Dec 31, 2022 | 357.40 Mn |
| Sep 30, 2022 | 734.58 Mn |
| Jun 30, 2022 | 185.93 Mn |
| Mar 31, 2022 | 703.97 Mn |
| Dec 31, 2021 | 222.20 Mn |
| Sep 30, 2021 | 178.84 Mn |